Outcomes of Male Patients with Alport Syndrome Undergoing Renal Replacement Therapy
Johanna Temme(Universitätsmedizin Göttingen), Oliver Groß(Universitätsmedizin Göttingen), Óscar Zurriaga(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Anneke Kramer(Amsterdam University Medical Centers), Enrico Verrina, James Heaf(Zealand University Hospital), Patrik Finne(Hospital District of Helsinki and Uusimaa), Kitty J. Jager(Amsterdam University Medical Centers), Runólfur Pálsson(Reykjavík University), F. Jarraya(University of Sfax), Julio Pascual Santos, Reinhard Kramar(Statistics Austria), Katharina Lange(Universitätsmedizin Göttingen), Friedo W. Dekker(Leiden University Medical Center), Pietro Ravani(University of Calgary), Maurizio Postorino(National Academies of Sciences, Engineering, and Medicine), Andries J. Hoitsma(Radboud University Nijmegen), Wendy Metcalfe, Gerhard‐Anton Müller, Anna Varberg Reisæter(Oslo University Hospital)
Cited by 74
Related Papers
Multiorgan and Renal Tropism of SARS-CoV-2
|New England Journal of Medicine|2020|1.9k
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877
External validation of prognostic models: what, why, how, when and where?
|Clinical Kidney Journal|2020|808
When do we need competing risks methods for survival analysis in nephrology?
|Nephrology Dialysis Transplantation|2013|674